Long Short Idea: Short Coinbase, Long Pfizer
The launch of a Bitcoin ETF could have a significant impact on Coinbase, the largest cryptocurrency exchange in the United States. Some analysts believe that the ETF could lead to a decline in trading volume on Coinbase, as investors may choose to trade Bitcoin through the ETF rather than directly on the exchange. Additionally, the ETF could put pressure on Coinbase's margins, as it would allow investors to borrow Bitcoin for less than they can borrow on the exchange.
Pfizer, on the other hand, is a pharmaceutical company with a strong track record of innovation. The company has a pipeline of promising drugs that could generate significant revenue in the coming years. Pfizer is also well-positioned to benefit from the aging population in the United States and other developed countries.
Short Coinbase
There are several reasons why investors might want to short Coinbase. First, as mentioned above, the launch of a Bitcoin ETF could lead to a decline in trading volume on Coinbase. This would hurt Coinbase's revenue and profits. Second, the ETF could put pressure on Coinbase's margins. As investors borrow Bitcoin for less through the ETF, they will be less willing to pay high fees to borrow Bitcoin on Coinbase. This could squeeze Coinbase's profits.
Long Pfizer
There are also several reasons why investors might want to go long on Pfizer. First, the company has a strong track record of innovation. Pfizer has developed a number of blockbuster drugs, and the company has a pipeline of promising drugs that could generate significant revenue in the coming years. Second, Pfizer is well-positioned to benefit from the aging population in the United States and other developed countries. As the population ages, there will be a greater need for drugs to treat chronic diseases such as cancer and heart disease. Pfizer is a leader in these areas, and the company is well-positioned to capitalize on this trend.
Conclusion
The long-short idea of shorting Coinbase and going long on Pfizer is a contrarian trade. This trade is based on the belief that the launch of a Bitcoin ETF will be bad for Coinbase, but good for Pfizer. This trade is risky, but it has the potential to generate significant returns if the ETF does indeed hurt Coinbase's business.
Disclaimer
Please note that this is not investment advice. Investing in securities involves risk, and you could lose money. Before investing in any security, you should do your own research and consider your own risk tolerance.
Pfizer, on the other hand, is a pharmaceutical company with a strong track record of innovation. The company has a pipeline of promising drugs that could generate significant revenue in the coming years. Pfizer is also well-positioned to benefit from the aging population in the United States and other developed countries.
Short Coinbase
There are several reasons why investors might want to short Coinbase. First, as mentioned above, the launch of a Bitcoin ETF could lead to a decline in trading volume on Coinbase. This would hurt Coinbase's revenue and profits. Second, the ETF could put pressure on Coinbase's margins. As investors borrow Bitcoin for less through the ETF, they will be less willing to pay high fees to borrow Bitcoin on Coinbase. This could squeeze Coinbase's profits.
Long Pfizer
There are also several reasons why investors might want to go long on Pfizer. First, the company has a strong track record of innovation. Pfizer has developed a number of blockbuster drugs, and the company has a pipeline of promising drugs that could generate significant revenue in the coming years. Second, Pfizer is well-positioned to benefit from the aging population in the United States and other developed countries. As the population ages, there will be a greater need for drugs to treat chronic diseases such as cancer and heart disease. Pfizer is a leader in these areas, and the company is well-positioned to capitalize on this trend.
Conclusion
The long-short idea of shorting Coinbase and going long on Pfizer is a contrarian trade. This trade is based on the belief that the launch of a Bitcoin ETF will be bad for Coinbase, but good for Pfizer. This trade is risky, but it has the potential to generate significant returns if the ETF does indeed hurt Coinbase's business.
Disclaimer
Please note that this is not investment advice. Investing in securities involves risk, and you could lose money. Before investing in any security, you should do your own research and consider your own risk tolerance.
Trade active:
short order filled at 160. wish me luck
Comment:
The final short order filled at $170. SL is at $180
Comment:
im long pfizer the same amount
Comment:
Moved the sl to 190 on coin .
Comment:
$120 is the target . still keeping my short positions.
Comment:
I toke 50% off my shorts on
COIN
and with that profit + margin I bought more ali baba.
here is why take a look at the video
COIN
and with that profit + margin I bought more ali baba. here is why take a look at the video
